Skin conditions
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
Search results
524 results
-
-
Ulcerative colitis
Everything NICE has said on managing ulcerative colitis in adults, children and young people in an interactive flowchart
-
Gastrointestinal conditions
Everything NICE has said on gastrointestinal conditions in an interactive flowchart
-
Crohn's disease
Everything NICE has said on managing Crohn's disease in children, young people and adults in an interactive flowchart
-
Atrial fibrillation
Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart
-
Low back pain and sciatica
Everything NICE has said on low back pain and sciatica in an interactive flowchart
-
Rheumatoid arthritis
Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart
-
Neuropathic pain
Everything NICE has said on pharmacological management of neuropathic pain in adults in non-specialist settings in an interactive flowchart
-
Social care for older people with multiple long-term conditions
Everything NICE has said on social care and support for older people with social care needs and multiple long-term conditions in an interactive flowchart
-
Patient experience in adult NHS services
Everything NICE has said on improving the experience of care for people using adult NHS services in an interactive flowchart
-
Irritable bowel syndrome in adults
Everything NICE has said on diagnosing and managing irritable bowel syndrome in adults in primary care in an interactive flowchart
-
Mental health problems in people with learning disabilities
Mental health problems in people with learning disabilities
-
Headaches
Everything NICE has said on the most common primary headache disorders in young people aged 12 years and older and adults in an interactive flowchart
-
Multimorbidity
Everything NICE has said on optimising care for people with 2 or more long-term health conditions in an interactive flowchart
-
Cannabis-based medicinal products
Everything NICE has said on cannabis-based medicinal products in an interactive flowchart.
-
Chronic pain (primary and secondary)
Everything NICE has said on assessing all chronic pain and managing chronic primary pain in people aged 16 years and over in an interactive flowchart.
-
Endometriosis
Everything NICE has said on diagnosing and managing endometriosis in an interactive flowchart
-
Spondyloarthritis
Everything NICE has said on diagnosing and managing spondyloarthritis in people aged 16 and over in an interactive flowchart
-
Osteoarthritis
Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart
-
Health of people in the criminal justice system
Everything NICE has said on managing the physical and mental health of people in prison, and the mental health of people in the criminal justice system
-
Head injury
Everything NICE has said on triage, assessment, investigation and management of head injury in infants, children and adults in an interactive flowchart
-
Postnatal care
Everything NICE has said on the essential care that every woman and her baby should receive in the first 6–8 weeks after birth in an interactive flowchart
-
Maternal and child nutrition
Everything NICE has said on maternal and child nutrition in an interactive flowchart
-
Social and emotional wellbeing for children and young people
Everything NICE has said on supporting the social and emotional wellbeing of children and young people in an interactive flowchart
-
Abortion care
Everything NICE has said on abortion care in an interactive flowchart.
-
Early-onset neonatal infection
Everything NICE has said on antibiotics for preventing and treating early-onset neonatal infection in an interactive flowchart
-
Developmental follow-up of children and young people born preterm
Everything NICE has said on developmental follow-up of children and young people born preterm in an interactive flowchart
-
Contraception
Everything NICE has said on contraceptive services, long-acting reversible contraception and sterilisation in an interactive flowchart
-
Neonatal jaundice
Everything NICE has said on diagnosing and treating jaundice in newborn babies under 28 days in an interactive flowchart
-
Antenatal and postnatal mental health
Everything NICE has said on antenatal and postnatal mental health in an interactive flowchart
-
Contraceptive services for under 25s
Everything NICE has said on contraceptive services for under 25s in an interactive flowchart
-
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis (ES29)
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis
-
COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 (ES24)
ES24 . Key messages The content of this evidence review was up to date on 1 April 2020. New evidence may have been published since
-
COVID-19 rapid evidence summary: Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (ES25)
ES25 . Key messages The content of this evidence review was up to date on 20 April 2020. New evidence may have been published since
-
COVID 19 rapid evidence summary: Anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis (ES26)
ES26 . Key messages The content of this evidence review was up to date on 13 May 2020. New evidence may have been published since
-
Antimicrobial prescribing: imipenem with cilastatin and relebactam (ES30)
Summary of the evidence on antimicrobial prescribing: imipenem with cilastatin and relebactam
-
Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)
Summary of the evidence on antimicrobial prescribing: delafloxacin
-
Antimicrobial prescribing: cefiderocol (ES31)
Summary of the evidence on antimicrobial prescribing: cefiderocol
-
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis (ES35)
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis
-
The percentage of patients with coronary heart disease, stroke or transient ischemic attack, diabetes and/or chronic obstructive pulmonary disease who have influenza immunisation in the preceding 1 August and 31 March
The percentage of patients with coronary heart disease, stroke or transient ischemic attack, diabetes and/or chronic obstructive pulmonary disease who
-
The percentage of patients with diabetes, on the register, in whom the last IFCC-HbA1c is 75 mmol/mol or less in the preceding 12 months
The percentage of patients with diabetes, on the register, in whom the last IFCC-HbA1c is 75 mmol/mol or less in the preceding 12 months
-
The percentage of patients with diabetes, on the register, who have a record of retinal screening in the preceding 12 months
The percentage of patients with diabetes, on the register, who have a record of retinal screening in the preceding 12 months Subject(s):
-
The percentage of patients with diabetes with a record of testing of foot sensation using a 10g monofilament within the preceding 12 months
The percentage of patients with diabetes with a record of testing of foot sensation using a 10g monofilament within the preceding 12 months
-
The percentage of patients with hypertension or diabetes and a BMI of 27.5 kg/m2 or more (or 30 kg/m2 or more if ethnicity is recorded as White) in the preceding 12 months who have been referred to a weight management programme within 90 days of the BMI being recorded
The percentage of patients with hypertension or diabetes and a BMI of 27.5 kg/m2 or more (or 30 kg/m2 or more if ethnicity is recorded as White) in...
-
The percentage of patients with cancer, diagnosed within the preceding 24 months, who have a patient Cancer Care Review using a structured template within 12 months of diagnosis
The percentage of patients with cancer, diagnosed within the preceding 24 months, who have a patient Cancer Care Review using a structured template...
-
Proportion of young people aged 12-18 years with diabetes who have had their urinary albumin recorded in the previous 12 months
Proportion of young people aged 12-18 years with diabetes who have had their urinary albumin recorded in the previous 12 months Subject(s):
-
The percentage of women under the age of 55 years who are taking antiepileptic drugs who have a record of information and counselling about contraception, conception and pregnancy in the preceding 12 month
NICE indicators. NM03 schizophrenia guidance.
-
The percentage of women with schizophrenia, bipolar affective disorder or other psychoses under the age of 45 years who have been given information and advice in the previous 12 months about pregnancy, conception or contraception tailored to their pregnancy and contraceptive intentions
NICE indicators. NM78 epilepsy guidance.
-
Percentage of patients on the learning disability register with Down's Syndrome aged 18 and over who have a record of blood TSH in the previous 15 months (excluding those who are on the thyroid disease register)
Percentage of patients on the learning disability register with Down's Syndrome aged 18 and over who have a record of blood TSH in the previous 15...
-
The percentage of patients with a new diagnosis of dementia recorded in the preceding 1 April to 31 March with a record of FBC, calcium, glucose, renal and liver function, thyroid function tests, serum vitamin B12 and folate levels recorded between 6 months before or after entering on to the register
The percentage of patients with a new diagnosis of dementia recorded in the preceding 1 April to 31 March with a record of FBC, calcium, glucose,...